Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name BI 907828
Trade Name
Synonyms BI907828|BI-907828|Brigimadlin
Drug Descriptions

BI 907828 is an MDM2 inhibitor that potentially inhibits tumor growth and improves anti-tumor immunity (PMID: 31201607; Cancer Res 2018;78(13 Suppl):Abstract nr 4866).

DrugClasses MDM2 Inhibitor 23
CAS Registry Number 2095116-40-6
NCIT ID C156709

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BI 907828 BI 907828 3 5
BI 907828 + Ezabenlimab BI 907828 Ezabenlimab 1 2
BI 907828 + Ezabenlimab + Miptenalimab BI 907828 Ezabenlimab Miptenalimab 0 1
BI 907828 + Rifampin BI 907828 Rifampin 0 0


Additional content available in CKB BOOST